Stocks · News reference

RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

Aug 6, 2026, 6:04 PMBenzinga Newsdesk

RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 10, 2026, 11:58 AMBenzinga Newsdesk
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100
Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.
Read original at benzinga
ZBH
BenzingaAug 7, 2026, 1:29 PMBenzinga Newsdesk
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106
Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.
Read original at benzinga
ZBH
BenzingaAug 6, 2026, 4:47 PMBenzinga Newsdesk
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.
Read original at benzinga
ZBH